This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Sep 14:341:c4538.

doi: 10.1136/bmj.c4538.

Screening for prostate cancer

Gerald L Andriole Jr

PMID: 20843936
DOI: 10.1136/bmj.c4538

Editorial

Screening for prostate cancer

Gerald L Andriole Jr. BMJ. 2010.

. 2010 Sep 14:341:c4538.

doi: 10.1136/bmj.c4538.

Author

Gerald L Andriole Jr

PMID: 20843936
DOI: 10.1136/bmj.c4538

No abstract available

PubMed Disclaimer

Comment in

Screening for prostate cancer. Consider the harms.
Bewley S. Bewley S. BMJ. 2010 Oct 26;341:c5811. doi: 10.1136/bmj.c5811. BMJ. 2010. PMID: 20978045 No abstract available.

Comment on

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials.
Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, Dahm P. Djulbegovic M, et al. BMJ. 2010 Sep 14;341:c4543. doi: 10.1136/bmj.c4543. BMJ. 2010. PMID: 20843937 Free PMC article.

Similar articles

"Screening for prostate cancer".
Gohagan JK, Kramer BS, Greenwald P. Gohagan JK, et al. Am J Prev Med. 1994 Jul-Aug;10(4):245-6. Am J Prev Med. 1994. PMID: 7528519 No abstract available.
Prostate cancer screening.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2008 Nov 3;50(1298):85-6. Med Lett Drugs Ther. 2008. PMID: 18978703 Review. No abstract available.
Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.
Shteynshlyuger A, Andriole GL. Shteynshlyuger A, et al. J Urol. 2011 Mar;185(3):828-32. doi: 10.1016/j.juro.2010.10.079. Epub 2011 Jan 15. J Urol. 2011. PMID: 21239021
Prostate specific antigen for detecting early prostate cancer.
Ilic D, Green S. Ilic D, et al. BMJ. 2009 Sep 24;339:b3572. doi: 10.1136/bmj.b3572. BMJ. 2009. PMID: 19778970 No abstract available.
PSA screening--a review of recent studies.
Schröder FH. Schröder FH. Eur J Cancer. 2009 Sep;45 Suppl 1:402-4. doi: 10.1016/S0959-8049(09)70065-6. Eur J Cancer. 2009. PMID: 19775647 Review. No abstract available.

See all similar articles

Cited by

Involving a Citizens' Jury in Decisions on Individual Screening for Prostate Cancer.
Mosconi P, Colombo C, Satolli R, Carzaniga S; Steering Committee; Scientific Committee. Mosconi P, et al. PLoS One. 2016 Jan 11;11(1):e0143176. doi: 10.1371/journal.pone.0143176. eCollection 2016. PLoS One. 2016. PMID: 26751212 Free PMC article.
Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia.
Hsiao CJ, Tzai TS, Chen CH, Yang WH, Chen CH. Hsiao CJ, et al. Dis Markers. 2016;2016:8915809. doi: 10.1155/2016/8915809. Epub 2016 Mar 15. Dis Markers. 2016. PMID: 27065039 Free PMC article.
Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
Pron G. Pron G. Ont Health Technol Assess Ser. 2015 May 1;15(10):1-64. eCollection 2015. Ont Health Technol Assess Ser. 2015. PMID: 26366236 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information